Substance Modalities
We observed a high prevalence of marijuana vaporization and smoking, and a surprisingly high utilization of inhalational methods for CBD. CBD is often less frequently asked about among CF healthcare teams, and many CF care providers feel unprepared to answer questions regarding CBD9. Given the potential for worsening lung disease and respiratory symptoms10, it is vital to routinely discuss both marijuana and CBD usage, counsel, and discuss modalities. Inhaling any substance can exacerbate airway inflammation and hasten lung damage, especially in those already afflicted with underlying lung disease9. Furthermore, alternative forms of marijuana and CBD, such as edibles and topical solutions, present challenges due to their higher cost11, limited accessibility12, and potential interactions with CFTR modulator drugs13, thereby potentially complicating their usage as an alternative to CF management strategies.